195 related articles for article (PubMed ID: 20349046)
1. NP-184[2-(5-methyl-2-furyl) benzimidazole], a novel orally active antithrombotic agent with dual antiplatelet and anticoagulant activities.
Kuo HL; Lien JC; Chung CH; Chang CH; Lo SC; Tsai IC; Peng HC; Kuo SC; Huang TF
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):495-505. PubMed ID: 20349046
[TBL] [Abstract][Full Text] [Related]
2. NP-313, 2-acetylamino-3-chloro-1,4-naphthoquinone, a novel antithrombotic agent with dual inhibition of thromboxane A(2) synthesis and calcium entry.
Kuo HL; Lien JC; Chang CH; Chung CH; Kuo SC; Hsu CC; Peng HC; Huang TF
Br J Pharmacol; 2011 Apr; 162(8):1871-83. PubMed ID: 21232029
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet effect of NQ12: a possible mechanism through the arachidonic acid cascade.
Jin YR; Han XH; Lee JJ; Lim Y; Kim TJ; Yoo HS; Hong JT; Lee CK; Yun YP
J Pharmacol Sci; 2007 Oct; 105(2):193-200. PubMed ID: 17951980
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet and antithrombotic activities of NQ301, 2-chloro-3-(4-acetophenyl)-amino-1,4-naphthoquinone.
Kang WS; Ryu CK; Chung KH; Ko MW; Joo JC; Yuk DY; Yoo HS; Yun YP
Biol Pharm Bull; 1999 Dec; 22(12):1284-7. PubMed ID: 10746156
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.
Kwon HW; Shin JH; Lim DH; Ok WJ; Nam GS; Kim MJ; Kwon HK; Noh JH; Lee JY; Kim HH; Kim JL; Park HJ
BMC Complement Altern Med; 2016 Dec; 16(1):508. PubMed ID: 27927214
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and antithrombotic activities of Korean Red Ginseng.
Yu JY; Jin YR; Lee JJ; Chung JH; Noh JY; You SH; Kim KN; Im JH; Lee JH; Seo JM; Han HJ; Lim Y; Park ES; Kim TJ; Shin KS; Wee JJ; Park JD; Yun YP
Arch Pharm Res; 2006 Oct; 29(10):898-903. PubMed ID: 17121186
[TBL] [Abstract][Full Text] [Related]
7. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
Ting HJ; Khasawneh FT
Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
[TBL] [Abstract][Full Text] [Related]
8. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antithrombotic and antiplatelet activities of NQ304, a newly synthesized naphthoquinone derivative.
Yuk DY; Lee HY; Ryu CK; Hong JT; Kang WS; Yoo HS; Yun YP
Arzneimittelforschung; 2000 Mar; 50(3):254-9. PubMed ID: 10758777
[TBL] [Abstract][Full Text] [Related]
11. In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate.
Wienen W; Stassen JM; Priepke H; Ries UJ; Hauel N
Thromb Haemost; 2007 Jul; 98(1):155-62. PubMed ID: 17598008
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet, anticoagulant, and profibrinolytic activities of cudratricusxanthone A.
Yoo H; Ku SK; Lee W; Kwak S; Baek YD; Min BW; Jeong GS; Bae JS
Arch Pharm Res; 2014 Aug; 37(8):1069-78. PubMed ID: 24234914
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet and anticoagulant effects of "HN-11 500," a selective thromboxane receptor antagonist.
Schenk JF; Radziwon P; Fellier H; Breddin HK
Thromb Res; 2001 Jul; 103(2):79-91. PubMed ID: 11457465
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic and antiplatelet activities of Korean red ginseng extract.
Jin YR; Yu JY; Lee JJ; You SH; Chung JH; Noh JY; Im JH; Han XH; Kim TJ; Shin KS; Wee JJ; Yun YP
Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):170-5. PubMed ID: 17309520
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in Vitro and in Vivo Anticoagulant and Antiplatelet Activities of Amidino- and Non-Amidinobenzamides.
Lee SH; Lee W; Bae JS; Ma E
Molecules; 2016 May; 21(5):. PubMed ID: 27213328
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet, anticoagulant, and profibrinolytic activities of withaferin A.
Ku SK; Bae JS
Vascul Pharmacol; 2014 Mar; 60(3):120-6. PubMed ID: 24534482
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic activity of methanolic extract of Umbilicaria esculenta.
Kim MS; Lee KA
J Ethnopharmacol; 2006 May; 105(3):342-5. PubMed ID: 16384677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
